Melinta Therapeutics, LLC drugs

7 results

  • baxdela

    (delafloxacin meglumine)
    Melinta Therapeutics, LLC
    BAXDELA is indicated for adults with acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia caused by specific susceptible microorganisms, including MRSA and various strains of Streptococcus and Enterobacter. It should be used to mitigate drug-resistant bacteria development.
    Medication Details
    Drug Interactions

  • kimyrsa

    (oritavancin diphosphate)
    Melinta Therapeutics, LLC
    KIMYRSA® is indicated for treating adult patients with acute bacterial skin and skin structure infections (ABSSSI) caused by specific Gram-positive bacteria, including methicillin-susceptible and resistant Staphylococcus aureus, various Streptococcus species, and vancomycin-susceptible Enterococcus faecalis. Use only for proven or suspected susceptible infections.
    Medication Details
    Drug Interactions

  • orbactiv

    (oritavancin)
    Melinta Therapeutics, LLC
    ORBACTIV® (oritavancin) is indicated for treating adult patients with acute bacterial skin and skin structure infections caused by susceptible Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus and vancomycin-susceptible Enterococcus faecalis. It should be used to prevent drug-resistant bacteria and tailored based on culture results when available.
    Medication Details
    Drug Interactions